Bobby Darrel Smith, MD in Amory, MS - Anesthesiology

Bobby Darrel Smith, MD is a Anesthesiology physician based in Amory, Mississippi. Bobby Darrel Smith is licensed to practice in Mississippi (license number 08429) and his current practice location is 1105 Earl Frye Blvd, Amory, Mississippi. He can be reached at his office (for appointments etc.) via phone at (662) 256-7111.

NPI number for Bobby Darrel Smith is 1558380170 and his current mailing address is 123 Main St N, Amory, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1558380170.

Contact Information

	Bobby Darrel Smith, MD
	1105 Earl Frye Blvd, Amory, MS 38821-5500
	(662) 256-7111
	Not Available

Physician's Profile

Full Name	Bobby Darrel Smith
Gender	Male
Speciality	Anesthesiology
Location	1105 Earl Frye Blvd, Amory, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1558380170
Provider Enumeration Date: 07/18/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Bobby Darrel Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558380170	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	08429 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bobby Darrel Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bobby Darrel Smith, MD 123 Main St N, Amory, MS 38821-3416 Ph: (662) 256-7112	Bobby Darrel Smith, MD 1105 Earl Frye Blvd, Amory, MS 38821-5500 Ph: (662) 256-7111

News Archive

EC approves Janssen's DACOGEN for treatment of de novo acute myeloid leukaemia

Janssen-Cilag International NV announced today that the European Commission has approved the marketing authorisation for DACOGEN(decitabine) for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukaemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.

Researchers examine recommendations of televised medical talk shows

For millions of people around the world, televised medical talk shows have become a daily viewing ritual.

Most pregnant women do not know their recommended calorie intake, survey found

A survey conducted by the National Charity Partnership (NCP), U.K suggests that most of the women who participated are not sure on the amount of food they should intake while they are pregnant. According to the research that surveyed 2,100 U.K. women, only one-third of the expectant mothers were able to produce the correct answers to the questions asked to them.

Non-invasive method of checking teeth for cavities

Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.

Tobira completes $31 million Series B financing

Tobira Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative antiviral compounds to treat HIV disease, today announced the completion of a $31 million Series B financing. New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.

Bobby Darrel Smith, MD - Anesthesiology in Amory, MS